IntraLuminal completes $20 million financing:
This article was originally published in Clinica
IntraLuminal, which is developing products for the crossing and recanalisation of total occlusions, has completed the first tranche of a two-stage financing round. $20m is available immediately, with a further $10m triggered by milestones. The funds will be used for a continued rollout of the Carlsbad, California-based company's Safe-Cross TO crossing system, the selected introduction of the first generation SafeSteer system in the US and development of the second and next generation systems. Of the 4.3 million coronary artery patients worldwide undergoing coronary and peripheral diagnostic procedures annually, 1.2m will have one or more total occlusions, IntraLuminal says.